[go: up one dir, main page]

GB2065658A - Azetidinone derivatives - Google Patents

Azetidinone derivatives Download PDF

Info

Publication number
GB2065658A
GB2065658A GB8040697A GB8040697A GB2065658A GB 2065658 A GB2065658 A GB 2065658A GB 8040697 A GB8040697 A GB 8040697A GB 8040697 A GB8040697 A GB 8040697A GB 2065658 A GB2065658 A GB 2065658A
Authority
GB
United Kingdom
Prior art keywords
compound
formula
compound according
azetidin
lactam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8040697A
Other versions
GB2065658B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of GB2065658A publication Critical patent/GB2065658A/en
Application granted granted Critical
Publication of GB2065658B publication Critical patent/GB2065658B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compounds of the formula <IMAGE> useful as intermediates in the preparation of beta-lactam structures can be obtained by reacting a penicillin having the formula: <IMAGE> with a compound R3COOH in the presence of trimethyl phosphite, where R2 is hydrogen or a protected amino or amido group; COOA is a carboxylic group or an ester or salt thereof; and R3 is an alkyl or aryl radical or a heterocyclic residue, to give a compound of formula: <IMAGE> The latter compound can be converted a into the intended compound of formula IV by successive isomerisation of the olefinic bond, oxidative cleavage of the olefinic bond to give an oxamide and hydrolytic removal of the oxalyl group to give the compound of formula IV.

Description

1
GB 2 065 658 A
1
SPECIFICATION
Improvements in or relating to azetidinones
10
This invention relates to processes for preparing azetidinonesand to new azetidinones obtainable by those processes. In particular, the invention relates to a new process for preparing functionalized azetidinones which are useful intermediates for the synthesis of known and new |3-lactam structures. Among the latter clavulanic acid (I) (described and claimed in the German patent application DOS 2.517.316) and 1-oxa-1-diethiacephalosporins (II) (described and claimed in the German patent application DOS.2.355.209 and in the Belgian patent 832.174) have shown inhibition of |3-lactamases and, respectively, a remarkable antibiotic activity.
10
T5
20
h h
J—N —
(I)
oh h h
COOH
h h
RNH*4—
cooh
00
15
20
The starting materials of the present invention are azetidinones having the formula (III) below, which compounds are the subject of our copending Patent Application No. 79 03290 (publication number 25 2012766A) the disclosure of which is incorporated herein by reference.
25
30
35
h h r2.
3 4
O
0
ii i I'll OCRg
#1 V
COO A
35,45
cm)
30
35
where R2 is hydrogen or a protected amino or protected amido group; COOA is a carboxylic group or an 40 ester or salt thereof; and R3 is an alkyl oraryl radical or a heterocyclic residue. The protecting moiety of the protected amino group can be any of these suitable for use in protecting amino groups of penicillins, for example phthaloyl, phenoxyacetyl, trityl or carbobenzoxy.
The protected amino or amido group is conveniently a phthalimido, benzamido, phenylacetamido or phenoxyacetamido group; for example:
45
50
55
(%H5)3 CNH, CeH5CONH, C£H£CHpCONH, C6H50CH2C0NHor
®rN
R3 can be substituted or unsubstituted. Where it is alkyl it preferably has one to six carbon atoms, for example methyl or ethyl; where it is aryl it can be, for example, a phenyl radical. Phenyl radicals of special interest are those having halogen substituents, for example mono - or other chloro-substituted phenyl radicals. Treatment of compounds (III) with a weak base in an aprotic solvent affords the conjugated esters (VI) (eq.2). o t1 f »
jittlH OCR3
40
45
50
55
'rt,u»OCR3
/
■NnA
cooa cooa
(eg. 2)
35, 4S
Cm)
35, 4s
(m)
2
GB 2 065 658 A
2
10
The weak base used in the above process is conveniently a tertiary amine, for example triethylamine. An example of a suitable aprotic- solvent is methylene chloride.
The compounds of formula VI where R2, R3and - COOA have the meanings ascribed to them above are, with one exception, new compounds. The exception is the compound where R3 is CH3 and R2 is C6HsO-CH2-CO-NH which has been previously reported among the products formed in the reaction of penicillin esters with mercury {[(> acetate [R.J. Stoodley and N.R. Whitehouse, J.C.S. Perkin 1,1974,181 J.
Compounds (VI) can be transformed into the simpler azetidinones (IV) which are the subject of the present invention by known procedures which effect oxidative cleavage oftheolefinic bond followed by hydrolitic removal of theoxalyl group in the resulting oxamides (VII) (eq.3) [J.H.C. Nayleretal., J.C.S. Chem.Comm., 1972,229 and J.C.S. Perkin 1,1976,447; R.D.G. Cooper et al., J. Am. Chem. Soc., 94,1021 (1972)].
10
15
H
RZ»
H ? I '"OCR3 *2—
COOA
COOA
O
, If HH11OCR3
(EQ.3)
15
20
35,45
w
35.45 (3ZIT)
3S.4S
(W
20
25 The processes exemplified in eqs. 2 and 3 can be performed so as to give good yields with no loss of 25
stereochemistry.
The compounds of formulae VII and IV where R2, R3 and A have the meanings ascribed in them above are,
with one exception, new compounds. The exception is the compound of formula IV where R2 is C6H50-CH2-C0-NH and R3 is CH3-.
3q Clavulanic acid structurally related racemic novel 1-oxa-1-dethia penam derivatives have been prepared 30 from the optically active (3S, 4S)-4-acetoxy-3-phenoxy acetamidoazetidin-2-one of structure (IV) (R2=C6H5—O—CH2—CO—NH, R3=CH3) [R.G. Alexander and R. Southgate, J.C.S. Chem. Comm. 7377,405]
and from racemic 4-acetoxy-azetidin-2-one of structure (IV) (R2=H, R3=CH3) [Belgian Patent No. 844.533; A.G. Brown, D.F. Corbett and T. Trefor Howarth, J.C.S. Chem. Comm., 1977,359].
35 Racemic 4-acetoxy-azetidin-2-one of structure (IV) (R2=H, R3=CH3) has been also used forthe synthesis of 35 known -lactam antibiotics [H.W. Schnabel, D. Grimmond, H. Jensen: Liebigs Ann. Chem. 1974,477; G.
Schmid, K.K. Prasad, T. Petrilzka; Helv. Chim. Acta, 59,2294 (1976)].
The following examples illustrate the preparation of compounds of formula IV in accordance with the invention (Examples 10-14) and compounds formed as intermediates during such preparation, the starting 4q compounds being the subject of the previously mentioned copending patent application No. 79 03290 to 40 which reference should be made for further details.
EXAMPLE 1
(3S,4Sj-1-( 1-methoxycarbonyl-2-methytprap-1-enyl)-4-acetoxy-3 (phthalimido}azetidin-2-one
45
50
55
COOMe cooMe
45
50
55
A solution of (3S,4S)-1-(1 °c-methoxycarbonyl-2-methylprop-2-enyl)-4- acetoxy-3 (phthalimido)azetidin-2-one (3.36 g, 8.7 mmole) dissolved in methylene chloride (80 ml) was treated with few drops of triethylamine.
3
GB 2 065 658 A
3
After standing overnight, the solvent was evaporated in vacuo to yield the title compound quantitatively as a colorless oil.
P.M.R. (CDCI3,8):
I.R. (CHCI3, cm-1) 10 M.S. (m/e):
CH,
2.12 (s,CH3—CO); 2.12 and 2.29 (s.
CH 3/
,C=C); 3.85 (s, COOCH3);
5.35 and 6.52 (d, J = 1.5, p- lactam protons); 7.82 (br, aromatic protons). 1780,1730.
386,344,326,231,189.
10
EXAMPLE 2
(3S,4S)-1-( 1-methoxycarbonyl-2-methylprop- 1-eny/)-4-acetoxy-3 (phenoxyacetamidojazetidin-2-one
15
20
11 H H H
0 u
11 H
H"
1—N
f'
COOMe u COOMe
25 The title compound was obtained with a procedure similar to that given in Example 9.
15
20
25
P.M.R. (CDCI3,5):
30
CH
2.02 and 2.25 (s, CH3-C=C); 2.11 (s, CH3CO); 3.77 (s, COOCH3);
4.56 (s, O-CH2-CO); 5.10 (dd, J = 8 and J = 1.5 cps, C-3 p-lactam proton); 6.23 30
(d, J = 1.5 cps, C-4 |3-lactam proton); 6.85 - 7.45 (m, N-H and aromatic protons).
EXAMPLE 3
35 (3S,4S)- 1-(1-methoxycarbonyl-2-methylprop- 1-enyl)-4-(2-chloro)benzoyloxy-3 (phenoxyacetamido)azetidin- 35 2-one
40
45
50
o o 9'- 0 0 9^~
UNI>
O f o
COOMe COOMe
The title compound was obtained with a procedure similar to that given in Example 9.
H3C
40
45
50
P.M.R. (CDCI3r 6): 55 I.R. (CHCI3, cm-1):
2.00 and 2.20 (s, CH3 -C=C); 3.72 (s, COOCH3); 4.50 (s, 0-CH2-C0);
5.18 (dd, J = 8 and J = 1.5 cps, C-3 fi-lactam proton); 6.53 (d, J = 1.5 cps, C-4 (B-lactam proton); 6.85 - 8.00 (m, N-H and aromatic protons).
3410,1785,1725,1700 55
4
GB 2 065 658 A
4
EXAMPLE 4
(3S, 4SJ-1-( 1-methoxycarbonyl-2-methyIprop- 1-enyl)-4(4-chforo)benzoyfoxy-3 (phthalimido)azetidin-2-one
10
15
0 >-nsA
O 1
cooMe
CL
COOMe
The title compound was obtained with a procedure similarto that given in Example 9.
H3C
20 P.M.R. (CDCI3,6):
I.R. (CHCI3, cm-1):
2.09 and 2.23 (s, CH3 -C=C); 3.74 (s, COOCH3); 5.46 and 6.67
(d, J = 1.5 cps, p-lactam protons); 7.15 - 7.90 (m, aromatic protons).
1790,1780,1725.
EXAMPLE 5
25 (3S, 4SJ- 1-methyloxafyl-4-acetoxy-3 (phthalimido)azetidin-2-one
10
15
20
25
30
35
30
35
(3S, 4S)-1-(1-methoxycarbonyl-2-methylprop-1-enyl)-4-acetoxy-3 (phthalimido) azetidin-2-one (1.93 g, 5 40 mmole) dissolved in methylene chloride (300 ml) was cooled down to -78°C and treated with a stream of 03 40 till saturation of the solvent occurred. An excess of sodium metabisulphite was added and the stirred mixture was allowed to reach room temperature naturally. Enough water to dissolve the salt was added, the organic layer was separated, washed with saturated NaCI solution (3 x 100 ml) and dried (Na2S04). The solvent was evaporated in vacuo to give the title compound as white crystals (Et20) in quantitative yield. 45 45'
P.M.R. (CDCI3,5): 2.16 (s, CH3CO); 3.94 (s, COOCH3); 5.48 and 6.72 (d,J = 2 cps, p-lactam protons); 7.82 (br, aromatic protons).
EXAMPLE 6
50 (3S,4Sj- 7-methyloxa/y/-4-acetoxy-3(phenoxyacetamido)azetidin-2-one 50
5
GB 2 065 658 A
5
The title compound was obtained as white crystals (Et20) with a procedure similar to that given in Example 5.
P.M.R. (CDCI3,5):
I.R. (CHCI3, cm"1): M.S. (m/e):
m.p.:
2.13 (s, CH3-CO); 3.93 (s, COOCH3); 4,58 (s, 0-CH2-C0); 4.77 (dd, J = 8 and J
= 2 cps, C-3 p-lactam proton); 6.69 (d, J = 2 cps, C-4 p-lactam proton); 6.80 - 5
7.60 (m, N-H and aromatic protons).
3440,1840,1770,1730,1700.
364,304,245,235,211.
121-3°C.
10
EXAMPLE 8
(3S, 4S)-1-methyloxalyl-4-(4-ch/oro)benzoyloxy-3(phenoxyacetamido)azetidin-2-one
"15
20
On On
^^-O-CH^-C-N H H P-ChQ)-CL Q-0-CHj-C-B.S I P"^"^3"CL
cooMe
"nY°
0 COOMe
10
15
20
25 The title compound was obtained with a procedure similar to that given in Example 5.
I.R. (CHCI3, cm-1): mp.:
3440,1830,1755,1730,1700. 53-5°C.
30 EXAMPLE 8
(3S,4S)-1-methyloxa/yl-4-(2-chloro)benzoyloxy-3 (phenoxyacetamido)azetidin-2-one
25
30
35
40
Fhhh f hhh g0-C^C-NHjlp-C{} <C>°-CH2"C-\M/"C0
0 X
coc
COOMe COOMe
The title compound was obtained with a procedure similar to that given in Example 5. ■45 P.M.R. (CDCI3, 6):
I.R. (CHCI3, cm
-1\.
50 EXAMPLE 9
(3S,4S)-1-methyloxalyl-4-(4-chloro)benzoyloxy-3 (phtalimidojazetidin-2-one
35
40
3.84 (s, COOCH3); 4.48 (s, 0-CH2-C0); 4.98 (dd, J = 8 and J = 2 cps, C-3 45 P-lactam proton); 6.78 (d, J = 2 cps, C-4 p-lactam proton); 6.80 - 7.90 (m, N-H and aromatic protons).
3430,1830,1755,1720,1700.
50
COOMe cooMe
6
GB 2 065 658 A
6
The title compounds was obtained with a procedure similarto that given in Example 5.
I.R. (CHCI3, cm'1): 1830,1780,1750,1725
5 EXAMPLE 10
(3S,4S)-4-acetoxy-3-(phthalimido}azetidin-2-one
10
15
10
15
COOMe
20 (3S,4S)-1-methyl oxalyl-4-acetoxy-3 (phthalimido)azetidin-2-one (1.8 g, 5 mmole) dissolved in methanol (40 ml) was treated with a catalytic amount of sodium methoxide. After few hours the resulting precipitate was filtered off, the filtrate was evaporated in vacuo and the residue triturated with Et20 and MeOH to afford more crystals. The combined precipitates were washed with cold ether and dried. The title compound was obtained in quantitative yield.
25
P.M.R. (CDCI3,6): 2.12 (s, CH2-CO); 5.37 and 6.12 (d, J = 1.5, p-lactam protons); 6.74 (br, N-H);
7.75 (br, aromatic protons).
I.R. (CHCI3, cm-1): 3430,1805,1785,1745,1730.
[a]D = -57.1° (CHCI3)
30 m.p.: 185-7°C
EXAMPLE 11
(3S,4S)-4-(4-chloro)benzoyloxy-3(phthalimido)azetidin-2-one
35
40
45
,°"0\=/'CL
C00Me
20
25
30
35
40
45
The title compound was obtained with a procedure similar to that given in Example 10. 50 P.M.R. (CDCI3,5):
I.R. (CHCI3, cm-1):
5.55 and 6.43 (d, J = 1.5 cps, p-lactam protons); 7.20-8.10 (m, N-H and aromatic protons).
3420,1800,1725
EXAMPLE 12
55 (3S, 4S)-4-acetoxy-3(phenoxyacetamido)azetidin-2-one
50
55
V O OO
^^O-CHr-C-N W « O-C-CH3 <Q^O-CH2-(!:-K J HpJ_CH£
COOMe
7
GB 2 065 658 A
7
The title compound was obtained as white crystals with a procedure similar to that given in Example 10.
P.M.R. (CDCIg, 6): 2.09 (s, CH3-CO); 4.47 (s, 0-CH2-C0); 4.86 (dd, J=8 and J=1.5, C-3
p-lactam proton); 5.87 (d, J = 1.5 cps, C-4 p-lactam proton); 6.70 - 7.63 (m, N-H and aromatic protons).
3420,1795,1745,1690.
LR. (CHCI3, cm"1):
10
15
EXAMPLE 13
(3S, 4S)-4-(4-chloro)benzoyloxy-3(phenoxyacetamido)azetidin-2-one
<£>'V-NO-CCL
"Ny0
cooMe cf
-KIH
10
15
20 The title compound was obtained as white crystals with a procedure similar to that given in Example 10. P.M.R. (CDCI3,5):
4.54 (s, 0—CH2-CO); 4.89 (dd, J = 8 and J = 1.5 cps, C-3 p-lactam proton); 6.05 (d, J = 1.5 cps, C-4 p-lactam proton); 6.70-7.90 (dd and m, N-H and aromatic protons).
25
30
35
EXAMPLE 14
(3S,4S)-4-(2-ch/oro) benzoyloxy-3(phenoxyacetamido)azetidin-2-one
O O CL O O CL
<Q)-0-CHp-C-K ^ H fife <^-°-CHp-C-S ^ y
|«N \*~ i»v
NH
20
25
30
35
The title compound was obtained as white crystals with a procedure similar to that given in Example 10.
40
I.R. (CHCI3, cm"1):

Claims (11)

  1. 45 1. A compound of the formula: 50
    3420,1785,1750,1690.
    H H ' || k3-4 |^0cr3
    cf
    •NH
    40
    45
    50
    55
    3S, 4-S
    Civ)
    55
  2. 2. A compound according to Claim 1, in which R2 is hydrogen or a protected amino group or a protected amido group and R2 is an alkyl or aryl radical or a heterocyclic residue but excluding those compounds in
    60 which R3 is methyl and R2 is C6H50 - CH2-CO-NH and in which R3 is methyl and R2 is hydrogen. 60
  3. 3. A compound according to Claim 1, in which R2 is phenoxyacetamido.'
  4. 4. A compound according to Claim 1,2, or 3 in which R3 is methyl.
  5. 5. A compound according to Claim 1,2 or 3 in which R3 is a phenyl radical.
  6. 6. A compound according to Claim 5, in which R3 is a chloro-substituted phenyl radical.
    65
  7. 7. A compound according to Claim 6, in which R3 is an o-chlorophenyl orp-chlorophenyl radical. 65
    8
    GB 2 065 658 A
    8
  8. 8. The compound named in the title of any oneof Examples 10 to 14.
  9. 9. A process for preparing a compound as claimed in Claim ^substantially as described herein.
  10. 10. A process for preparing a compound as claimed in Claim 1, substantially as described in any oneof Examples 10 to 14.
    5
  11. 11. A compound of formula IV obtained by the process of Claim 9 or 10.
    Printed for Her Majesty's Stationery Office, by Croydon Printing Company Limited, Croydon, Surrey, 1981. Published by The Patent Office, 25 Southampton Buildings, London, WC2A1AY, from which copies may be obtained.
GB8040697A 1977-11-18 1979-01-31 Azetidinone derivatives Expired GB2065658B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4806477 1977-11-18
GB7903290A GB2012766B (en) 1977-11-18 1979-01-31 Synthesis of functionalized azetidinones

Publications (2)

Publication Number Publication Date
GB2065658A true GB2065658A (en) 1981-07-01
GB2065658B GB2065658B (en) 1982-10-20

Family

ID=26266202

Family Applications (2)

Application Number Title Priority Date Filing Date
GB8040697A Expired GB2065658B (en) 1977-11-18 1979-01-31 Azetidinone derivatives
GB7903290A Expired GB2012766B (en) 1977-11-18 1979-01-31 Synthesis of functionalized azetidinones

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB7903290A Expired GB2012766B (en) 1977-11-18 1979-01-31 Synthesis of functionalized azetidinones

Country Status (4)

Country Link
JP (1) JPS5476570A (en)
BE (1) BE869503A (en)
DE (1) DE2839646A1 (en)
GB (2) GB2065658B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997042170A1 (en) * 1996-05-06 1997-11-13 Biochimica Opos S.P.A. A process for the preparation of azetidinones

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997042170A1 (en) * 1996-05-06 1997-11-13 Biochimica Opos S.P.A. A process for the preparation of azetidinones

Also Published As

Publication number Publication date
BE869503A (en) 1978-12-01
GB2012766A (en) 1979-08-01
GB2012766B (en) 1982-05-19
JPS5476570A (en) 1979-06-19
GB2065658B (en) 1982-10-20
DE2839646A1 (en) 1979-05-23

Similar Documents

Publication Publication Date Title
DE69308154T2 (en) METHOD FOR PRODUCING TAXAN DERIVATIVES
US4595532A (en) N-(substituted-methyl)-azetidin-2-ones
CS276964B6 (en) Process for preparing 6&#39;-acylaminopenicillanoyl-oxymethyl esters of penicillanic acid 1,1-dioxide
MX2015002640A (en) New process.
FI970427A0 (en) Process for the preparation of antimicrobial compounds
US3943123A (en) Novel beta-lactams and novel process
US4124593A (en) Aromatic dicarboximides
US4122262A (en) Intermediates and methods for preparing 7-acylamino-8-oxo-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid derivatives
US3963712A (en) 3-Halo-cephalosporins
GB2065658A (en) Azetidinone derivatives
US4200572A (en) Substituted azetidinones
US4122086A (en) Isopenicillins
US4166816A (en) Methods and intermediates for preparing cis-4-oxoazetidine intermediates
US4072674A (en) Cis-4-oxoazetidine intermediates and methods of preparing them
DD285604A5 (en) PROCESS FOR THE PREPARATION OF ENOL ETHERS AND ESTERS
US4711956A (en) Penicillin derivatives
EP0001715A2 (en) Azetidinone antibiotics and their pharmaceutical formulations and use
GB2137203A (en) Improvements in or relating to a process for producing b-lactam compounds
CA1146544A (en) Process for penicillin epimerization
US4171303A (en) Process for the preparation of reactive penicillanic acid and cephalosporanic acid derivatives
US4751296A (en) Process for 4-halomethyl-azetidinones by cyclization of O-acylhydroxamates
Farina et al. Synthesis and acylating properties of 4, 5‐dihydro‐6H‐1, 3, 4‐oxadiazin‐6‐ones
IE57626B1 (en) Improvements in or relating to the preparation of azetidinone sulfinic acids from cephalosporin sulfones
GB1566262A (en) 3 - amino - 4 - oxoazetidine derivatives
US4187375A (en) Process for preparing oxazine ring compounds

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee